[1]
D. P. Roggeri, E. Zanon, C. Biasoli, and A. Roggeri, “Extended Half-life rFVIII for the Treatment of Hemophilia A: Drugs Consumption and Patients’ Perspective”, FE, vol. 21, no. 1, Jun. 2020.